RxDoctor Payments Data

M Ashraf Mansour, MD

Vascular Surgery · Grand Rapids, MINPI 1487697421

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (44.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Medtronic at 48.5% of the total. Reporting peaked in 2019 at $6,550 and has fallen 64.7% since, to $2,309 in 2025.

$13,973in general payments, 2019–2025

Across 87 payments — averaging $160.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$7K
  • Silk Road Medical, Inc.$2K
  • Boston Scientific$2K
  • W. L. Gore & Associates, Inc.$2K
  • Endologix LLC$171
  • Aroa Biosurgery Incorporated$160
  • plus $1K from 16 others
$45,693in research payments, 2019–2025

Across 43 payments — averaging $1062.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • W. L. Gore & Associates, Inc.$46K

What the payments were for

  • Royalty or licence$6,24845%
  • Travel & lodging$2,82420%
  • Food & beverage$4,90035%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,973 in reported general payments places this provider in the 80th percentile of 183 vascular surgery providers in Michigan.

See all vascular surgery providers in Michigan

Medicare billing

Part B allowed, 2024
$60,420
Medicare patients
246
Services billed
400

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate41$637

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Grand Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →